Delphi Diagnostics today announced the appointment of Eric Lindquist as Chief Financial Officer, effective April 1, 2026. Mr. Lindquist brings decades of leadership experience across pharmaceutical ...
Peer-reviewed manuscript demonstrates the Endocrine Activity Index TM Recurrence Risk (EAI RR) enhances risk stratification beyond Recurrence Score® and is predictive of endocrine therapy benefit ...
HOUSTON, Nov. 4, 2025 /PRNewswire/ -- Delphi Diagnostics announces the upcoming presentation of four scientific abstracts, including one platform presentation highlighting new clinical data supporting ...
The study, which analyzed 659 patient samples from the PACS-01 clinical trial, demonstrates that EAI RR provides meaningful prognostic and endocrine-predictive information beyond the 21-gene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results